Press Releases
Mar. 12, 2026
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
Indeterminate
GlobeNewswire, Inc.
Feb. 25, 2026
ARRAY Technologies Reports Financial Results for the Fourth Quarter and Full Year 2025
Indeterminate
GlobeNewswire, Inc.
Feb. 25, 2026
STAND UP FOR SCIENCE: CDC-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU CANCELLED
Neutral
EIN Presswire
Mar. 13, 2026
Vistra Appoints Kelsy Long as Senior Vice President of Marketing and Communications
Indeterminate
GlobeNewswire, Inc.
Feb. 25, 2026
CORRECTED PRESS RELEASE: Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
AASHTO Joins Engineering Workforce Consortium to Strengthen State Transportation Workforce Development
Indeterminate
GlobeNewswire, Inc.
Feb. 25, 2026
Three UAGC Faculty and Staff Recognized as IGI Global Scientific Publishing Ambassadors
Neutral
EIN Presswire
Feb. 24, 2026
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
Dynamic Stem Cell Therapy - 712579 - 02/11/2026
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
Feb. 24, 2026
AQ USA Inc., d.b.a Ross Healthcare Inc. - 719517 - 02/12/2026
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
Feb. 21, 2026
James Altucher Named a Leading Technology Expert following Recent Presentation
Indeterminate
GlobeNewswire, Inc.
Mar. 13, 2026
Growing Awareness Of Sleep Health Driving The Sleep Market 2026
Neutral
EIN Presswire
Feb. 19, 2026
James Altucher Recognized as a “Top Technology and Financial Strategist” Following Series of Early Innovation Calls
Indeterminate
GlobeNewswire, Inc.